LONDON, October 31, 2011 /PRNewswire/ -- New tools build upon company's minimally-invasive Balloon Sinuplasty(TM) Platform to improve visualisation capabilities during

BOSTON, Sept.

MENLO PARK, Calif., March 2 /PRNewswire/ -- A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty(TM) technology to be safe when used by physicians in pediatric patients.

CHEVY CHASE, Md., Dec. 16 /PRNewswire/ -- New Enterprise Associates, Inc.

MENLO PARK, Calif., June 25 /PRNewswire/ -- Acclarent, Inc., a leading medical technology company dedicated to designing, developing, and commercializing products that address conditions affecting the ear, nose and throat (ENT) today announced the completion of a study evaluating the treatment of patients with Balloon Sinuplasty(TM) technology in the office setting.